Skip to main content

Amorepacific Shares Plunge 25% Amid Disappointing Q2 Results


    Amorepacific, a leading player in the Korean beauty industry, saw its stock plummet nearly 25% following the announcement of its second-quarter earnings, which fell significantly short of market expectations. This decline also resulted in a market capitalization loss of approximately 2.4 trillion KRW (about $2 billion USD).

On the trading day following the earnings release, Amorepacific's shares closed down 24.91% at 124,500 KRW, hitting an intraday low of 123,200 KRW. The company’s market capitalization dropped from 9.7 trillion KRW to 7.3 trillion KRW.

The decline was notably driven by heavy selling from foreign and institutional investors, who sold off 56.7 billion KRW and 140.5 billion KRW worth of shares, respectively. Amorepacific’s preferred stock also saw a significant decline, closing 21.37% lower at 36,600 KRW.

The main culprit behind this dramatic drop in stock price is Amorepacific’s weak financial performance in Q2. The company reported sales of 904.8 billion KRW and an operating profit of 4.2 billion KRW, marking year-over-year declines of 4.3% and 29.5%, respectively.

In response to these results, Korea Investment & Securities lowered its target price for Amorepacific from 240,000 KRW to 200,000 KRW, a 16.7% decrease. Analyst Kim Myung-ju cited underperformance in the Chinese market and disappointing results from subsidiary COSRX as key factors. COSRX’s sales fell slightly to around 143 billion KRW, with operating profit also declining compared to the previous quarter.

Kim explained that a fundamental overhaul of the sales strategy in China led to a significant drop in revenue. Additionally, duty-free sales fell by 25% year-over-year, further impacting the profitability of Amorepacific's domestic operations.

Hyundai Motor Securities analyst Ha Hee-ji also lowered the target price for Amorepacific from 230,000 KRW to 210,000 KRW, forecasting continued challenges through Q3 due to the restructuring of the Chinese subsidiary and weak duty-free sales. Other major securities firms such as Mirae Asset Securities, NH Investment & Securities, Kiwoom Securities, Hana Securities, and Shinhan Investment Corporation also reduced their target prices for the company.

While the recent decline in Amorepacific’s stock price is likely to be short-term, the company’s future performance hinges on the recovery of its Chinese business and improvement in COSRX’s results. The potential for a rebound exists, but it will require strategic adjustments and market recovery in key regions.

Comments

Popular posts from this blog

Korean Beauty Trends & Industry News: 24-07-03

The K-Beauty Revolution Conquering the Global Beauty Market      Korean beauty products, known as K-Beauty, are rapidly rising in the global beauty market. By the end of last year, the number of cosmetic companies in Korea exceeded 31,524, tripling from 10,000 in 2017 in just six years. In the first half of this year alone, K-Beauty exports reached $4.81 billion, an increase of 17.8% from the previous year, making it one of the fastest-growing sectors, behind only semiconductors, computers, and ships. The key to K-Beauty's success lies in its rapid innovation and diverse product range. A recent example is American beauty influencer Darsie, who praised the K-Beauty brand Tirtir's dark-tone cushion foundation. Her positive review garnered over 38.8 million views and more than 10,000 comments, boosting Tirtir's new product to the top of Amazon's beauty category in the U.S. upon release. K-Beauty's strength in the global market is its quick product innovation. Japanese ...

Misleading Claims in Microneedle Skincare Products: 82 Cases Identified

     Recently, microneedle skincare products have gained significant popularity, but Korea’s Ministry of Food and Drug Safety (MFDS) has uncovered that over 80% of these products being sold online are making false or exaggerated claims. After reviewing 100 online posts, the MFDS found that 82 of them violated Korea’s cosmetics regulations, leading to requests for the posts to be blocked by the Korea Communications Standards Commission. The misleading advertisements primarily claimed that microneedles could penetrate deep into the skin layers or promised immediate pore reduction, both of which are not scientifically validated for general cosmetic products. Microneedles are a medical technology designed to deliver substances into the deeper layers of the skin, typically used in drugs and medical devices. However, in the cosmetics industry, these products generally do not have the same capabilities. Some companies falsely advertised their products as having effects similar t...